Vemurafenib Active Not Recruiting Phase 1 Trials for Advanced Cancers Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01531361Sorafenib or Crizotinib and Vemurafenib in Advanced Cancer
NCT01636622Study of Vemurafenib, Carboplatin, and Paclitaxel